A biotech/biopharma small cap and trends media channel for Content Carnivores.
Chicago
Joined October 2014
- Tweets16.8K
- Following1.8K
- Followers1.9K
- Likes50
$GOVX to Present at the Noble Capital Markets Emerging Growth Equity Conference December 3, 2024. Video webcast available the following day on buff.ly/2OS5KKp #mpox #immunocompromised #mva
1
213
$GOVX milestones met, including plans for a Phase 2 trial of Gedeptin for first recurrent head and neck cancer in combination with an immune checkpoint inhibitor. Full report here. buff.ly/3AJwQkj
166
The study emphasizes the importance of considering both arms of the immune system in assessing vaccine immunogenicity, particularly in the context of immunodeficiency. #vaccines #COVID19 #immunocompromised #MVA $GOVX buff.ly/48yOfrb
3
126
This conference is for innovators. See presentation time and company info. #biotech #demycolton #healthcare #BioFuture2023
buff.ly/3Lv6Gny
1
81
This conference is for innovators. See presentation time and company info. #biotech #demycolton #healthcare #BioFuture2023
buff.ly/3Lv6Gny
52
Innovators & Investors Come Together to Shape the Future of Healthcare. #biotech, #demy-colton, #innovators, #disruptors #BioFuture2023 Learn more and register here. buff.ly/2HTba69
29
GeoVax Announces Gedeptin® Presentation at the AACR-AHNS Head and Neck Cancer Conference. Another milestone for late-stage cancer patients with ongoing clinical trials. buff.ly/3JB6XUX
1
155
Be here during biotech's biggest week of the year. buff.ly/2ORIzlV #BiotechShowcase2023 #BiotechShowcase #digimed #medtech #biotech #pharma @demycolton @AIVITABio @Mediphage @OpusGenetics @Allergenis @Enveric_Bio $ENVB
All major biotech categories. buff.ly/2ORIzlV #BiotechShowcase2023 #digimed #medtech #biotech #pharma @demycolton
Entact Bio makes its Series A debut with $81M to launch protein enhancement platform buff.ly/3P4IGYO
A biotech startup using a high throughput platform to screen chemical compounds and natural substances for developing drugs and treatments for aging related diseases. buff.ly/2HTba69 #Biofuture2022 #biotechnology #nuclearphysics #therapy @demycolton
Developing a novel class of sensitisers to immune checkpoint blockade therapy. buff.ly/2HTba69 #Biofuture2022 #pharmaceutical #immune #therapy @demycolton
FDA approves J&J's BCMA-targeted bispecific for multiple myeloma buff.ly/3SF6nXT
Large insurer's decision to cover some prescription digital therapies may be a milestone for app makers buff.ly/3gQuwxh
Pacific Biosciences, known for niche DNA sequencing, looks to rival Illumina with new product launch buff.ly/3gK60Ou
Automatically building large databases of images and data on live cells and tissues for data mining, machine learning and breakthrough insights. buff.ly/2HTba69 #Biofuture2022 #biotechnology #data #cells #cellimaging #breakthrough #machinelearning @demycolton
